Vermillion Reports $73K in Q1 Revenues | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) - Vermillion yesterday filed its form 10-Q with the US Securities and Exchange Commission, in which it reported first-quarter 2010 revenues of $73,000, compared to no revenues for the first quarter of 2009.

For the three months ended March 31, the company's net loss rose to $11.6 million, or $1.14 per diluted share, four times its net loss of $2.8 million, or $0.44 per share, in Q1 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.